Headquartered in Denmark, William Demant Invest is a highly respected evergreen investment company, wholly owned by the charitable William Demant Foundation. William Demant Invest is the majority shareholder in Demant, the leading global hearing healthcare company, Össur, a global leader in non-invasive orthopaedics, as well as Vision RT, a market-leading UK-based medtech company.
The investment company also has significant holdings in Vitrolife (assisted reproduction), CellaVision (medical microscopy in the field of hematology), Revenio (ophthalmologic screening and diagnostics), Jeudan (real estate) and Borkum Riffgrund 1 (offshore wind farm). The total number of employees around the world within the William Demant Invest family counts more than 20,000.
William Demant Invest A/S
CVR no. 27761291